Follow The Filings

ONC position history

The shares of Beone Medicines (ONC) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q3: 1,100 shares, $247K, <0.01% of portfolio, New
  2. 2024 Q4: 1,100 shares, $203K, <0.01% of portfolio
  3. 2025 Q1: 1,100 shares, $299K, <0.01% of portfolio
  4. 2025 Q2: 1,100 shares, $266K, <0.01% of portfolio
  5. 2025 Q3: 2,200 shares, $750K, <0.01% of portfolio, Add +100.0%
  6. 2025 Q4: 1,100 shares, $334K, <0.01% of portfolio, Reduce −50.0%
  7. 2026 Q1: 1,100 shares, $327K, <0.01% of portfolio
  8. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders